{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:19:55Z","timestamp":1788394795341,"version":"build-2803163510"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/ajg.2011.443","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T08:06:07Z","timestamp":1324368367000},"page":"379-386","source":"Crossref","is-referenced-by-count":85,"title":["Double-Blind Randomized Trials of Single-Tablet Ibuprofen\/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers"],"prefix":"10.14309","volume":"107","author":[{"given":"Loren","family":"Laine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso E","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Y","family":"Grahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"key":"R2-12-20210210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/pds.755","article-title":"Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).","volume":"12","author":"Paulose-Ram","year":"2003","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"R3-12-20210210","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cgh.2006.04.010","article-title":"Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin.","volume":"4","author":"Wilcox","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-12-20210210","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","article-title":"Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the first international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents.","volume":"103","author":"Chan","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R5-12-20210210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2036.2008.03905.x","article-title":"Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.","volume":"29","author":"Rostom","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-12-20210210","first-page":"728","article-title":"Guidelines for prevention of NSAID-related ulcer complications.","volume":"104","author":"Lanza","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R7-12-20210210","first-page":"CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers.","volume":"4","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-12-20210210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","article-title":"National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs.","volume":"129","author":"Abraham","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"R9-12-20210210","first-page":"A36","article-title":"Use of GI protective agents and COX-2 selective inhibitors in 14394624 U.S. patients taking NSAIDs.","volume":"126","author":"Laine","year":"2004","journal-title":"Gastroenterology"},{"key":"R10-12-20210210","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2006.08.016","article-title":"Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.","volume":"4","author":"Goldstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-12-20210210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1572-0241.2007.01595.x","article-title":"Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.","volume":"103","author":"Abraham","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R12-12-20210210","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01795.x","article-title":"Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.","volume":"18","author":"Sturkenboom","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-12-20210210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2007.03358.x","article-title":"Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage.","volume":"26","author":"van Soest","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-12-20210210","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM199605303342204","article-title":"Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.","volume":"334","author":"Taha","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R16-12-20210210","first-page":"A611","article-title":"Famotidine (FAM) three times daily (tid) produces better gastric suppression and control than does twice daily (bid) administration of the same total daily dose.","volume":"136","author":"Tidmarsh","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"R17-12-20210210","first-page":"A612","article-title":"HZT-501, a novel combination of ibuprofen (Ibu) and famotidine (FAM), provides pharmacokinetics comparable to that of commercially available Ibu and Fam in a patient-friendly dosing form: evaluation in healthy and renally impaired subjects.","volume":"136","author":"Tidmarsh","year":"2009","journal-title":"Gastroenterology"},{"key":"R18-12-20210210","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/BF02229641","article-title":"The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.","volume":"15","author":"Van Groenendael","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"Suppl 1","key":"R19-12-20210210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.1988.tb00767.x","article-title":"Treatment of endoscopy-negative NSAID-induced upper gastrointestinal symptoms with cimetidine: an international multicentre collaborative study.","volume":"2","author":"Bijlsma","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-12-20210210","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","article-title":"Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane collaboration systematic review.","volume":"5","author":"Rostom","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-12-20210210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomized controlled trial.","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"R22-12-20210210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib vs. omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomized trial.","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 134","key":"R23-12-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00365528709090142","article-title":"Famotidine: a notable lack of drug interactions.","volume":"22","author":"Humphries","year":"1987","journal-title":"Scand J Gastroenterol"}],"updated-by":[{"DOI":"10.1038\/ajg.2012.244","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T00:00:00Z","timestamp":1343952000000}}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2011443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011443","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2011443.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201203000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:37:32Z","timestamp":1786541852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201203000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2011.443","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}